LEAH BYRD: Open Payments
NPI 1336497874 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 47 payments from 16 companies in 2025. Trend: 2023 $627 · 2024 $659 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $392 |
| Amgen Inc. | 13 | $259 |
| GlaxoSmithKline, LLC. | 2 | $66 |
| Aurinia Pharma U.S., Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| UCB, Inc. | 2 | $48 |
| Alexion Pharmaceuticals, Inc. | 2 | $41 |
| Genentech USA, Inc. | 2 | $39 |
| Radius Health, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: RINVOQ, SKYRIZI, KRYSTEXXA, BENLYSTA, LUPKYNIS, OTEZLA, EVENITY, SAPHNELO.
Industry payments across SC — which companies pay providers there.
